This specialty practice discussion group is intended for advanced practice professionals of APHON.... View more
This specialty practice discussion group is intended for advanced practice professionals of APHON. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
In the BMT setting, we use Aprepritant for conditioning regimens with high-emetogenic potential (if no drug-drug interactions), and also for patients with a prior history of significant CINV prior to coming to transplant. We only have the oral formulation at our institution (dosing below).
—————————— Stacy Wolf, RN,BMTCN,CPNP-AC,CPON Oakland Children’s Hospital Oakland, CA United States ——————————